CX-3800 series (Cylene)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCX-3800 series (Cylene)
Drug Alias Namesecond-generation quadruplex inhibitors (Cylene)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA modulators
TargetsDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCylene Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCylene Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A